Most Read News

Rupa & Company Limited has informed the Exchange about the re-affirmation of Credit Rating

Smc Global Securities Limited has submitted to the Exchange a copy of Disclosure under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI ( SAST) Regulations, 2011.

Ansal Housing Limited has informed the Exchange about Defaults on Payment of Interest/Principal

Hitachi Energy India Limited has informed the Exchange about press release dated 23-Aug-2022 titled Hitachi Energy India Ltd ramps up Power Quality Products manufacturing

Supriya Lifescience Limited has informed the Exchange that Record date for the purpose of Dividend is 02-Sep-2022.

In continuation to our letter dated August 22, 2022 bearing Reference no. CIL/CC/37/2022-23 regarding submission of E-voting Results of Postal Ballot and pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby enclosed the Report of the Scrutinizer on the Postal Ballot of the Company.

Vinati Organics Limited has informed the Exchange about Notice of Annual General Meeting to be held on 14-Sep-2022

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, we hereby inform you that the Board of Directors of the Company hasappointed Mr. Gurcharan Das (DIN 00100011) as Non-Executive Independent Director of theCompany, for a period of five years, with effect from September 1, 2022. The said appointment is subject to approval of the Shareholders of the Company.Mr. Das does not hold any shares in the Company. None of the Directors are related to Mr. Das. Also, he has provided a disclosure to effect that he is not debarred or disqualified fromholding the office of Director by virtue of any order from SEBI/MCA or any such statutory authority. A brief profile of Mr. Das is annexed for your kind perusal.

Compuage Infocom Limited has informed the Exchange about Investor Presentation

Unichem Laboratories Limited has informed the Exchange about press release dated 23-Aug-2022 pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem???s Carbamazepine Tablets